12:00 AM
Feb 21, 2011
 |  BC Week In Review  |  Company News  |  Deals

InterMune, Roche deal

InterMune disclosed in its 4Q10 earnings that in January it and Roche partnered to identify and develop next-generation protease inhibitors...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >